Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NLRP3 Inhibitors in Post-PCI Patients
NCT05130892Phase 4Completed
- Start
- Nov 2021
- Primary completion
- Feb 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine, tranilast, Oridonin in coronary artery disease (CAD). Started Nov 2021; status: completed.
02
Drugs
colchicinetranilastOridonin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05130892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05130892.